ArticleBrain and behavior2025
A Causal Association Between Drug Use and Cognitive Impairment: A Two-Sample Mendelian Randomization Study.
Article in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association of cognitive impairment with statin use in coronary artery disease across APO (ε) genotypes in AllofUS.medRxiv : the preprint server for health sciences · 2026Article
- A Causal Association Between Drug Use and Cognitive Impairment: A Two-Sample Mendelian Randomization Study.Brain and behavior · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionObservational studies have suggested a link between certain drugs and cognitive impairment. In this study, a two-sample Mendelian randomization (MR) approach was used to investigate the causal relationship between drug use and different types of dementia.
methodsWe utilized summary data from genome-wide association studies (GWAS) with populations of European ancestry. The primary analysis was conducted using inverse-variance weighted (IVW) methods; MR Egger, weighted median, and weighted model methods were used to validate the results. Horizontal pleiotropy and outlier detection were assessed via MR Egger and MR-PRESSO, respectively; Cochran's Q test evaluated heterogeneity, whereas leave-one-out analyses were used to evaluate the presence of predominant instrumental variables (IVs). Statistical power was calculated using the online tool mRnd to assess the robustness of MR estimates.
resultsThe IVW analysis indicated that antithrombotic agents (odds ratio [OR] = 2.12, 95% confidence interval [CI] = 1.03-4.34, p = 0.04), HMG CoA reductase inhibitors (OR = 1.36, 95% CI = 1.07-1.72, p = 0.01), and salicylic acid and derivatives (OR = 2.77, 95% CI = 1.44-5.32, p = 0.002) are a strong risk factor for dementia with Lewy bodies (DLB); diuretics (OR = 1.13, 95% CI = 1-1.27, p = 0.047) and calcium channel blockers (OR = 1.16, 95% CI = 1.04-1.29, p = 0.007) might be a risk factor for vascular dementia; thyroid preparations (OR = 1.03, 95% CI = 1.01-1.06, p = 0.01), diuretics (OR = 1.06, 95% CI = 1.02-1.11, p = 0.004), and immunosuppressants (OR = 1.07, 95% CI = 1.01-1.12, p = 0.001), are a risk factor for frontotemporal dementia; HMG CoA reductase inhibitors is a risk factor for dementia in Alzheimer disease (OR = 1.32, 95% CI = 1.05-1.65, p = 0.01). Moreover, antihistamines for systemic use showed some causal effect on cognitive performance (p < 0.05). The MR-Egger regression indicated that results were unaffected by horizontal pleiotropy. Moreover, no heterogeneity was detected. However, power analyses revealed that several associations had relatively low statistical power, suggesting that these findings should be interpreted with caution.
conclusionsOur findings suggest that certain drugs may causally affect dementia. Larger, well-designed MR studies may help establish the causal status of these dementia risk factors.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.